Can You Drive While Taking Meloxicam?

Meloxicam does not carry an outright ban on driving, and no law specifically prohibits getting behind the wheel while taking it. But the drug can cause dizziness, drowsiness, and slowed reaction times in some people, and research on the broader class of pain relievers it belongs to suggests a measurable increase in crash risk. Whether you personally can drive safely depends on how the drug affects you, what else you are taking, and how severe the underlying pain is without it.

What Meloxicam Does That Could Affect Driving

Meloxicam is a nonsteroidal anti-inflammatory drug, or NSAID, commonly prescribed for arthritis, back pain, and other chronic inflammatory conditions. Most people think of NSAIDs as straightforward pain pills with stomach-related side effects. Dizziness and drowsiness tend to get less attention, but they appear on the drug’s label for good reason. NSAIDs can cross into the brain, and among their off-target effects are central nervous system symptoms including dizziness, headaches, and drowsiness.

A randomized, placebo-controlled crossover study tested what a single 7.5 mg dose of meloxicam did to psychomotor performance in healthy volunteers. It found that meloxicam significantly reduced motor reaction time by about 16% compared to baseline, and that this effect differed from placebo.¹ A faster motor reaction time might sound like a good thing, but in the context of that study’s full battery of tests, what it reveals is that the drug alters the central nervous system’s handling of incoming signals. Driving relies on a coordinated chain of perceiving, deciding, and reacting. Anything that changes one link in that chain changes how you handle the unexpected on the road.

Not everyone who takes meloxicam will notice these effects. The dizziness and drowsiness listed on the label occur in a minority of users. But the people who do experience them often underestimate how impaired they are, a pattern that shows up across many medication classes.

NSAIDs and Crash Risk in the Real World

The strongest reason to take this question seriously is not laboratory reaction-time data but what happens on actual roads. A review of medications and impaired driving published in The Annals of Pharmacotherapy noted that one study found a roughly 58% higher crash risk among patients taking NSAIDs. A separate case-control study found an even larger increase, about 70%, in the rate of at-fault crashes among NSAID users.² Those numbers cover NSAIDs as a class, not meloxicam specifically, and the studies could not fully separate the effect of the drug from the effect of the pain that led someone to take it. Still, the size of the increase is hard to wave away.

For context, a 58% increase in crash risk is in the same ballpark as some widely recognized driving impairments. The fact that it comes from a class of drugs most people consider benign is part of the problem. Drivers taking something they view as “just an anti-inflammatory” are less likely to monitor themselves for impairment than drivers who know they have taken a sedative or an opioid.

When Other Medications Make It Worse

Meloxicam on its own might cause mild dizziness in some users. Combined with other drugs, the picture can get significantly worse. The review that documented NSAID-related crash risk specifically flagged that the risk of at-fault crashes was significantly greater when ACE inhibitors (a common blood pressure medication) were taken alongside NSAIDs.² Since many people on meloxicam for arthritis also take blood pressure medication, this overlap is not rare.

The interaction picture becomes even more concerning when sedating drugs enter the mix. A large population-based screening study found that the combination of the anti-anxiety drug alprazolam, meloxicam, and the antifungal fluconazole was associated with more than double the risk of unintentional traumatic injury compared to what would be expected from the individual drugs alone.³ That particular three-drug combination may not be common, but the principle matters: if you are taking meloxicam alongside anything that affects alertness or blood pressure, the combined effect on your ability to drive safely can be more than the sum of the parts.

Practically, this means you should think about your full medication list, not just the meloxicam bottle. Ask your pharmacist whether any of your other prescriptions interact with it in ways that could affect alertness or coordination. The interaction does not have to be dramatic to matter at highway speeds.

The Chronic Pain Side of the Equation

Here is where the driving question gets genuinely complicated. Meloxicam might slightly impair some aspects of your driving performance. But chronic pain, the very condition the drug is treating, also impairs driving. A systematic review of the research on chronic pain and driving behavior found evidence that pain itself can increase crash risk and alter how people drive.⁴ Pain competes for your attention. It slows your processing. It makes it harder to check mirrors, turn your head, and maintain the sustained focus that long drives require.

That same review noted that many people with chronic pain adopt risk-compensating strategies on their own, like avoiding night driving, taking fewer long trips, or pulling over when pain flares. Those adaptations are sensible, but the review also found considerable variability in who actually adopts them. Some people push through, and some genuinely cannot tell how much their pain is affecting their driving in the moment.

This creates a real tension. If your pain is bad enough to significantly impair your driving, then taking meloxicam and getting your pain under control could actually make you a safer driver, even if the drug itself carries a small risk of dizziness. If your pain is mild and well-controlled, you might be introducing unnecessary risk by taking a drug that could make you drowsy behind the wheel. There is no universal answer. What matters is the net effect on your ability to drive, and that requires honest self-assessment.

Older Adults and People with Existing Health Conditions

If you are over 65 or managing multiple health conditions alongside your pain, the driving question deserves extra attention. NSAIDs are a leading cause of drug-related health problems in the elderly and in patients with comorbidities, and those problems extend beyond the well-known stomach and kidney concerns to include central nervous system effects like dizziness.⁵

Several factors converge in older adults to make this riskier. Kidney and liver function decline with age, which means the drug stays in your system longer and reaches higher concentrations than it would in a younger person. Older adults are more likely to be taking multiple medications, increasing the chance of the interactions discussed earlier. And the dizziness that a 35-year-old might shrug off can become a serious fall or crash risk for someone in their 70s, whose balance and reaction time are already less robust.

Animal studies have shown that meloxicam at sustained doses can affect the liver and kidneys, reinforcing why long-term use warrants monitoring.⁶ While that research was conducted in rats and does not translate directly to human dosing, it aligns with what clinicians already know about NSAID toxicity: the longer you take these drugs and the more vulnerable your organs are, the more careful you need to be. When organ function is compromised, the drug’s CNS effects can become more pronounced and less predictable, which feeds directly back into driving safety.

If you are an older adult on meloxicam, the practical advice is straightforward. When you first start the drug or when your dose changes, avoid driving until you know how you respond. If you have been on it for a while and feel fine, you are probably at lower risk, but stay alert to gradual changes in how the medication affects you, especially if your kidney function has shifted or another drug has been added to your regimen.

Why Most People Never Think Twice About It

A study of hospital outpatients who were prescribed medications carrying driving warnings found that only about half recalled even seeing the warning label on their medication.⁷ Among those who did notice the label, about three-quarters said they followed the advice. That still leaves a large proportion of people who either missed the warning entirely or dismissed it.

The same study found that patients had very high confidence in their ability to judge whether a medication was personally affecting them. This is the heart of the problem. People assume they would know if they were impaired. But mild drowsiness and slightly slower reaction times are not things you necessarily feel. You do not get a mental alarm telling you that your ability to react to a child running into the street has degraded by 15%. The subjective experience of feeling “fine” is not a reliable gauge of actual psychomotor performance.

Meloxicam sits in a particularly dangerous spot in the awareness landscape. It is not a sleeping pill. It is not an opioid. It is an anti-inflammatory that most people mentally file alongside ibuprofen. Prescribers often do not emphasize driving caution the way they would for, say, a muscle relaxant. The warning on the label, if noticed at all, competes for attention with a long list of other side effects. The result is that the subset of people who are genuinely affected by the drug’s CNS effects are unlikely to have been warned in a way that sticks.

A Practical Approach to Deciding Whether to Drive

Since there is no legal ban and no absolute medical prohibition, the decision comes down to your own situation. A few practical guidelines can help you make a reasonable call:

• First dose, first week: When you start meloxicam or change your dose, avoid driving until you know how the drug affects you. If a week goes by and you have not felt dizzy or unusually drowsy, you are probably in the clear for routine driving.
• Check your full medication list: If you also take blood pressure medications, sedatives, anti-anxiety drugs, or anything else that can cause drowsiness, treat the combination with more caution than you would treat meloxicam alone.
• Be honest about pain: If your pain is severe enough to distract you from driving and meloxicam brings it under control, the net effect on your safety could be positive. If your pain is mild and manageable without medication, consider whether the small risk of drug-related impairment is worth it before a drive.
• Monitor over time: Changes in kidney or liver function, new medications, or aging can all shift how meloxicam affects you. Something that was fine six months ago may not be fine today.
• Do not rely on feeling normal: Subtle impairment does not announce itself. If you are in a higher-risk group or on multiple medications, consider having someone else drive during periods when the drug is at peak levels in your blood, typically a few hours after taking it.

The “can I drive on this?” question is one that surprisingly few patients ask their doctors, and even fewer get a clear answer to. With meloxicam, the honest answer is that most people drive on it without incident. But a meaningful minority experience effects that make driving riskier than they realize, and the research on NSAIDs and crashes suggests this is not a trivial concern.

What the Law Says, and What It Doesn’t

No country specifically bans driving on meloxicam or other over-the-counter-class NSAIDs. However, impaired driving laws in most jurisdictions are written broadly enough to cover impairment from any substance, not just alcohol or illegal drugs. If you are involved in a crash and a responding officer determines that you are impaired, the fact that your impairment came from a legally prescribed anti-inflammatory does not protect you from a charge. The law cares about whether you were fit to drive, not about which substance made you unfit.

This legal gray area is particularly relevant because of the combination issue. If you take meloxicam with a benzodiazepine like alprazolam, the combined impairment could be obvious enough to attract law enforcement attention even though each drug individually might not have been. Insurance implications can also come into play: if an insurer can argue that you were on medications known to impair driving and were warned about it, that argument can complicate a claim.

The practical takeaway is that “my doctor prescribed it” is not a legal shield. Your responsibility as a driver is to be fit to drive, regardless of what is making you unfit. With something like meloxicam, the risk is low enough for most people that it rarely comes up. But if you are combining it with other sedating medications, you are entering territory where both the medical risk and the legal exposure become real.

Why Your Pharmacist Might Be More Helpful Than Your Doctor on This

Doctors prescribe meloxicam to treat your pain. Pharmacists dispense it and, in most health systems, are specifically trained to counsel patients on side effects and drug interactions. If you want a practical, personalized assessment of whether your medication combination poses a driving risk, the pharmacist is often better positioned to give it. They can see your full list of active prescriptions, flag interactions, and tell you which time of day to take each drug to minimize overlap of peak sedation windows.

Pharmacists also have access to drug interaction databases that go well beyond what your prescribing physician typically checks during a ten-minute appointment. Given that the risk with meloxicam comes less from the drug alone and more from its interactions with everything else you take, this kind of comprehensive review is where the real safety value lies. Most pharmacists will do it if you simply ask. Few patients do.